Innovation for Health - 13 February 2020
Contact I4H Bootcamp Global Investor Forum
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Werner Verbiest

Global Head, Janssen Diagnostics
Werner Verbiest

Session

11:30 - 12:45
Precision Medicine

Werner joined Johnson & Johnson in 1991 with the International Clinical R&D group of the Janssen Research Foundation, where he was active in HIV drug development and Hepatitis B vaccine development. In 1997, Werner joined Virco, as Project Director, Business Development. He was promoted to Managing Director, Virco Ireland in 2002 and became Vice President, New Products and Pharma Business.
He is currently Global Head Janssen Diagnostics, comprising the legacy organizations of Virco, Veridex and Johnson and Johnson’s Companion Diagnostics Center of Excellence. Over these years, he has been active in all phases of HIV clinical trial strategy and implementation, biomarker development (Collaborative Surrogate Marker Validation working groups with FDA and EMA), and has contributed to numerous papers and presentations on pharmacogenomics and personalized medicine.

In his current role as Global Head, Werner plays a leading role in advocating for and actualizing a personalized medicine approach within JnJ, but also outside JnJ, including several board seats in different “precision medicine” and Dx organizations.

Abstract

Prediction, prevention, precision medicine, towards tailor made approaches in healthcare.
Werner Verbiest will introduce and lead a panel discussion on the need for well targeted vaccines, diagnostics and individual patient oriented therapies. The future of health care is evolving into a personalized one. People are to be considered as unique - treatments will become more specific and targeted.

In the panel at innovation for health - Rotterdam February 14 - we have some high level speakers that can bring deep insights and have aspirational opinions.

Please join Werner, listen in, discuss and get inspired for your own field of activities.
Marcel Levi
University College London Hospitals

13 February
Jan van de Winkel
Genmab

13 February
Annemarie Jorritsma
NVP

13 February
Ton Rijnders
Lygature & Oncode Institute

13 February
Koen Kas
UGhent & HealthSkouts

13 February
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

12 & 13 February

Claudia Rijcken
pharmi

13 February

Inge Huitinga
Netherlands Brain Bank

13 February
Wiro Niessen
Erasmus MC, TU Delft & Quantib

13 February
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Koenraad Wiedhaup
McKinsey & Company
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
TheSocialMedwork
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Nadine Rouleaux
Maastricht University
Charlotte Kluit
MSD
Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Jan de Kerpel
Kempen & Co
Wim Van Hecke
icoMetrix
Wiesje van der Flier 
Alzheimercentrum Amsterdam
Niels Prins
Brain Research Center & Alzheimercentrum Amsterdam
Marco Blom
Alzheimer Nederland
Edwin Moses
Achilles Therapeutics & Evox Therapeutics
Carl Moons
Health Innovation Initiative Holland
Jan Kimpen
Philips
Linda van de Burgwal 
Vrije Universiteit Amsterdam
Onno van de Stolpe
Galapagos
Ton van der Steen
Erasmus MC, Medical Delta & STW
Sangbreeta Moitra 
Founder, International Keynote Speaker & Global Strategist
Eline Vrijland-van Beest
NightBalance & Philips
Kim Peters
Healthnovum
Gideon Bevelander
Johnson & Johnson Innovation
Giuseppe Marzio
Chiaro
Wijnand IJsselsteijn
Eindhoven University of Technology
Francesco De Rubertis
Medicxi
André van de Sande
André van de Sande Consultancy BV
Travis McCready
President and CEO, Massachusetts Life Sciences Center
Kees van der Klauw
e/MTIC & NL AI Coalition
Maroeska Rovers
Health Innovation Initiative Holland
Christina Takke 
V-Bio Centures
Focco Vijselaar 
Ministerie van Economische Zaken en Klimaat
Juliette Audet 
Forbion
Felice Verduyn 
LSP
Thijs Cohen Tervaert 
INKEF
Tjarda Molenaar
NVP
Willemijn Vader 
VitroScan B.V.
Thomas Hankemeier 
Leiden University
Henk-Jan Guchelaar
Leiden University Medical Center
Jos Lunenberg
ENPICOM BV
Peter de With
Eindhoven University of Technology
Natal van Riel
Eindhoven University of Technology
Bart van Zijll Langhout
Janssen Strategic Alliances EMEA & Janssen NL Campus Lead
Jan Peter Balkenende
Former Prime Minister
Elena Fernandez-Kleinlein
JLABS EMEA
Robert Vries
Hubrecht Organoid Technology
Peter Roevens
Janssen Pharmaceutica NV
Stefan Luzi
Gilde Healthcare
Peter Haasjes
Nextgenventures
Brigitte Drees 
Pivot Park
Femke van de Hoef
Loyens & Loeff
Dries Fransen van de Putte
Loyens & Loeff
Rob de Ree
Biogeneration Ventures
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.